General MedicationsORALGeneric
INDOMETHACIN
INDOMETHACIN
Standard Dose
25MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview INDOMETHACIN is listed in Drugs@FDA under application 018858 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient INDOMETHACIN Form and strength CAPSULE;ORAL - 25MG Sponsor RISING Submission history Latest submission status date: 2024-11-21 00:00:00.
Structured Monograph
Clinical summary
Approval overview INDOMETHACIN is listed in Drugs@FDA under application 018858 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient INDOMETHACIN Form and strength CAPSULE;ORAL - 25MG Sponsor RISING Submission history Latest submission status date: 2024-11-21 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.